Certified by Founder Lodge 
                                        
                                        Mission BioCapital
 
                                                 United States  -  Cambridge, Massachusetts 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $88,000,000
                                            6 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Mission BioCapital is a VC firm making pivotal early-stage investments in biotech companies. We support companies with lab space, capital, and strategic partners; idea to exit.
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   QurAlis | 
                                                            March, 10 ,2023 | Series B | $88,000,000 | 
   Mediar Therapeutics | 
                                                            March, 15 ,2023 | Unknown | $105,000,000 | 
   Nocion Therapeutics, Inc. | 
                                                            March, 06 ,2024 | Series B | $62,000,000 | 
   Integrated Biosciences, Inc. | 
                                                            October, 04 ,2024 | Seed | $17,000,000 | 
   Alessa Therapeutics, Inc. | 
                                                            December, 13 ,2024 | Seed | $15,000,000 | 
   Sensorium Therapeutics | 
                                                            September, 03 ,2025 | Series A | $25,000,000 | 
                                                
  QurAlis
  Mediar Therapeutics
  Nocion Therapeutics, Inc.
  Integrated Biosciences, Inc.
  Alessa Therapeutics, Inc.
  Sensorium Therapeutics
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)